1-7 of 7
Timothy W Farren
Close
Sort by
Journal Articles

Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL)

Timothy W. Farren, Ph.D, Fengting Liu, MD Ph.D, Marion G. Macey, Ph.D, Thomas J. Kipps, MD, PhD, Noel Warner, Samir G. Agrawal
Journal: Blood
Blood (2013) 122 (21): 2572.
https://doi.org/10.1182/blood.V122.21.2572.2572
Published: 2013
Journal Articles

Both PI3K p110α and p110δ Isoforms Control CD160-Mediated CLL Cell Viability and Cytokine Production

Timothy W. Farren, Ph.D, Fengting Liu, MD Ph.D, Samir G. Agrawal
Journal: Blood
Blood (2013) 122 (21): 4124.
https://doi.org/10.1182/blood.V122.21.4124.4124
Published: 2013
Journal Articles

Early Detection of Minimal Residual Disease in Biological Prognostic Risk Groups in Chronic Lymphocytic Leukaemia (CLL) Utilizing the Novel CD160FCA Assay

Timothy W Farren, Fengting Liu, Marion Macey, Michael Jenner, MD, PhD, FRCPath, Samir Agrawal
Journal: Blood
Blood (2011) 118 (21): 2832.
https://doi.org/10.1182/blood.V118.21.2832.2832
Published: 2011
Journal Articles

The Prognostic Significance of Monoallelic Versus Biallelic 13q Deletions in Patients with Chronic Lymphocytic Leukemia,

Smita Sinha, Timothy W Farren, Marianne Grantham, Samir Agrawal
Journal: Blood
Blood (2011) 118 (21): 3893.
https://doi.org/10.1182/blood.V118.21.3893.3893
Published: 2011
Journal Articles

Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells

Fengting Liu, Li Jia, MD, PhD, Timothy W Farren, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1784.
https://doi.org/10.1182/blood.V118.21.1784.1784
Published: 2011
Journal Articles

Differential and tumor-specific expression of CD160 in B-cell malignancies

Timothy W. Farren, Jerome Giustiniani, Feng-Ting Liu, Dimitris A. Tsitsikas, Marion G. Macey, James D. Cavenagh, Heather E. Oakervee, David Taussig, Adrian C. Newland, Maria Calaminici, Armand Bensussan, Michael Jenner, John G. Gribben, Samir G. Agrawal
Journal: Blood
Blood (2011) 118 (8): 2174–2183.
https://doi.org/10.1182/blood-2011-02-334326
Published: 2011
Includes: Supplemental data
Journal Articles

CD160 Expression in B-Cell Lymphoproliferative Disorders: Derivation and Validation of a New Three-Antigen Scoring System Improving Diagnostic Precision in B-Cell Malignancies.

Timothy W Farren, BSc(HONS), MIBMS, Feng-Ting Liu, MB, PhD, Claire Stephens, MSc, Dimitris Tsitsikas, MBBS, MRCP, Marion G Macey, PhD, FRCPath, Michael Jenner, MD, PhD, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4382.
https://doi.org/10.1182/blood.V114.22.4382.4382
Published: 2009